1/🚨New Episode🚨
The Lipid Panel Reimagined: #MindtheGap Segment
How do you interpret the #lipidpanel to help inform patients' risk for #cardiovascular disease? Do you use #ApoB? 🧐
🎧: link.chtbl.com/Lipids
Sponsor: go.amboss.com/CoreIM-E8
The Lipid Panel Reimagined: #MindtheGap Segment
How do you interpret the #lipidpanel to help inform patients' risk for #cardiovascular disease? Do you use #ApoB? 🧐
🎧: link.chtbl.com/Lipids
Sponsor: go.amboss.com/CoreIM-E8
2/ Unfortunately, our patient is stuck in "bumper-to-bumper" #cholesterol traffic 🚗!
See traffic analogy to understand why ApoB can give us information that LDL-C may not:
#Mindblown! 🤯
See traffic analogy to understand why ApoB can give us information that LDL-C may not:
#Mindblown! 🤯
3/ Overall, LOWER ⬇️ is better for both #LDL-C and #ApoB in terms of reducing #CV disease risk!
But #discordance between LDL-C vs. ApoB is actually quite common!
Take a look at the orange line to see how ApoB confers a higher CVD risk over time 👇
But #discordance between LDL-C vs. ApoB is actually quite common!
Take a look at the orange line to see how ApoB confers a higher CVD risk over time 👇
4/ Use this chart to help interpret #ApoB and #LDL-C results, looking at what percentile your patient falls across the population
5/Many thanks to all the "conductors" behind the scene of this busy #cholesterol intersection!
Host @gregorykatz @eucaryotic
Producers @ShreyaTrivediMD @YichiZzzzz
Graphics: @elizzieh08
🗒️: coreimpodcast.com/2022/12/15/rei…
Host @gregorykatz @eucaryotic
Producers @ShreyaTrivediMD @YichiZzzzz
Graphics: @elizzieh08
🗒️: coreimpodcast.com/2022/12/15/rei…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
